Cargando…

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors

Background: Thyroid toxicity is common following immune checkpoint inhibitor (ICI) treatment. Published studies estimate the incidence at 10-20%, although rates vary widely between different ICIs. The etiology of ICI-associated thyroid immune related adverse events (irAEs) is unknown & not all p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muir, Christopher Alan, Menzies, Alexander M, Clifton-Bligh, Roderick John, Long, Georgina V, Scolyer, Richard A, Tsang, Venessa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265849/ http://dx.doi.org/10.1210/jendso/bvab048.1790

Ejemplares similares

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

SAT-411 Vitamin D Levels and Risk of Thyroid Immune Related Adverse Events in Patients on Immune Checkpoint Inhibitors
por: Newman, Samantha Kass, et al.
Publicado: (2020)

Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes
por: Lui, David T W, et al.
Publicado: (2021)

FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
por: Maria Bignoli, Daniela Laura, et al.
Publicado: (2023)

SAT453 Endocrine Related Adverse Events Of Immune Checkpoint Inhibitors In Cancer Patients Visiting Tertiary Care Center In Saudi Arabia
por: Mohammed Alqahtani, Ali, et al.
Publicado: (2023)

SAT-416 Novel Autoantibodies for Thyroid-Specific Transcriptional Factors in Patients with Immune-Related Adverse Events Involving the Thyroid Gland
por: Yamauchi, Ichiro, et al.
Publicado: (2020)

SAT-418 Finding the Needles in the Haystack: Harnessing the Electronic Health Record to Find Thyroid Immune Related Adverse Events
por: Quandt, Zoe, et al.
Publicado: (2020)

OR18-06 Thyroid Function Test Abnormalities Secondary to Immune-Checkpoint Inhibitors: A Marker of Survival?
por: Ferreira, Joana Lima, et al.
Publicado: (2020)

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

OR28-07 Increased BMI Is Associated With Anti PD-1/PD-L1-Induced Thyroid Immune-Related Adverse Events
por: Pollack, Rena, et al.
Publicado: (2020)

OR19-5 Dissecting Thyroidal Pathways Activated by PD-L1 Blockade Identifies New Mechanisms for Thyroiditis Triggered by Immune Checkpoint Inhibitors
por: Hou, Hanxi, et al.
Publicado: (2022)

SAT-473 Thyroid Dysfunction in a Patient with Malignant Melanoma Treated with Immune Checkpoint Blockade
por: Gupta, Shaveta, et al.
Publicado: (2020)

MON-575 Clinical Implication of Sonographic Evaluation for Immune Checkpoint Inhibitor-Related Thyroiditis: A Case Series Study
por: Hong, A Ram, et al.
Publicado: (2019)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II
por: Burnett, Deborah L., et al.
Publicado: (2023)

OR19-5 The Impact Of High Dose Glucocorticoids On The Outcome Of Immune Checkpoint Inhibitor-related Thyroid Disorders And The Baseline TSH As A Predictive Biomarker
por: Min, Le, et al.
Publicado: (2019)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

SAT-492 Impending Thyroid Storm Induced by Checkpoint Inhibitors
por: Zhou, Ya, et al.
Publicado: (2020)

SAT-491 Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation
por: Martins, Diana Cruz, et al.
Publicado: (2020)

MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors
por: Brooks, Danielle, et al.
Publicado: (2019)

PSAT342 Hypothyroidism After Use Of Immune Checkpoint Inhibitor Therapy In Patient With Graves’ Disease
por: Sharma, Rajeev
Publicado: (2022)

Systemic immune inflammation index in differentiated thyroid cancers
por: Kars, Ayhan, et al.
Publicado: (2022)

ODP468 Checkpoint Inhibitor Immunotherapy- related Thyroid Disorders and Iodine Contrast Studies
por: Borges Espinosa, Luis, et al.
Publicado: (2022)

Hypothyroidism During Immune Checkpoint Inhibitor Therapy That Is Not Responsive to Thyroxin Substitution. A Peripheral T4-T3 Conversion Block?
por: Verelst, Faro, et al.
Publicado: (2021)

SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease
por: Muir, Christopher Alan, et al.
Publicado: (2020)

Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022)

The Immune Microenvironment of Hashimoto’s Thyroiditis Regulates the Glycosylation Modification of IgG
por: Cao, Yedi, et al.
Publicado: (2021)

SAT-414 A Single Center Retrospective Analysis and Review of Endocrinopathies from Immune Checkpoint Inhibitors Between 2007 and 2017
por: Shariff, Afreen Idris, et al.
Publicado: (2020)

Identification of RORg(+)T Cells as Key Players in Thyroid Autoimmunity From Checkpoint Immunotherapy
por: Lechner, Melissa G, et al.
Publicado: (2021)

PSAT235 The Role of Systemic Immune Activation in the Development of Thyroid Dysfunction in COVID-19
por: Kolpakova, Evgenia, et al.
Publicado: (2022)

RF11 | PSAT272 Suppressive Tumor Immune Microenvironment is Associated with Aggressive Differentiated Thyroid Cancer
por: Kotwal, Anupam, et al.
Publicado: (2022)

SAT471 Hearing-Related Adverse Events in Teprotumumab Oncology Clinical Trials
por: Smith, Terry J, et al.
Publicado: (2023)

OR10-3 Contributions of the Hypothalamus and Pituitary in Expressing the Thyroid Phenotype of SBP2 Deficiency: Other Regulatory Tiers in Addition to the Thyroid Gland
por: Korwutthikulrangsri, Manassawee, et al.
Publicado: (2019)

MON-LB85 Aberrant Glycan Expression Changes With the Phenotype of Follicular Thyroid Tumours
por: Lee, Kai Yin, et al.
Publicado: (2020)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
por: Herrmann, Sandra M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9c578a5vjm04hthqt9uhndk4nh